Management of Soft Tissue and Visceral Leiomyosarcomas.
Improved understanding of leiomyosarcoma's heterogeneity helps clinicians tailor management approaches and potentially reduce the substantial morbidity this rare cancer causes.
Leiomyosarcoma is a rare and heterogeneous malignant mesenchymal neoplasm associated with substantial morbidity and mortality. The record is retained for conservative triage based on its relevance and clinical trial.
What the study was
- Study design
- Clinical trial
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- JAMA Oncol
Why it surfaced
Retained as a clinical trial relevant to Precision oncology and genomic medicine; scoring is conservative from PubMed metadata and abstract only.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.